$213 Million is the total value of Pettee Investors, Inc.'s 151 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | Bristol-Myers Squibb | $4,945,000 | +7.2% | 74,007 | +1.2% | 2.32% | +4.3% |
| AXP | Buy | American Express | $2,426,000 | +17.0% | 14,681 | +0.2% | 1.14% | +13.9% |
| ZBH | Buy | Zimmer Biomet | $2,299,000 | +20.7% | 14,294 | +20.2% | 1.08% | +17.5% |
| HUM | Buy | Humana | $1,950,000 | +42.2% | 4,405 | +34.7% | 0.92% | +38.4% |
| DHI | Buy | D R Horton | $1,936,000 | +19.8% | 21,425 | +18.2% | 0.91% | +16.7% |
| DOV | Buy | Dover Corp. | $1,683,000 | +39.2% | 11,173 | +26.7% | 0.79% | +35.4% |
| WMT | Buy | Wal-Mart Stores | $1,513,000 | +14.6% | 10,732 | +10.4% | 0.71% | +11.6% |
| UNP | Buy | Union Pacific | $1,380,000 | +2.6% | 6,275 | +2.9% | 0.65% | 0.0% |
| HII | Buy | Huntington Ingalls Ind. | $1,260,000 | +52.9% | 5,980 | +49.3% | 0.59% | +48.7% |
| BDX | Buy | Becton Dickinson | $1,182,000 | +1.3% | 4,859 | +1.3% | 0.56% | -1.6% |
| FAF | Buy | First American Financial | $1,086,000 | +109.7% | 17,425 | +90.4% | 0.51% | +104.0% |
| CVS | Buy | CVS/Caremark | $977,000 | +49.2% | 11,705 | +34.5% | 0.46% | +45.3% |
| Buy | American Tower Corp. | $772,000 | +15.2% | 2,857 | +2.0% | 0.36% | +12.0% | |
| GS | Buy | Goldman Sachs | $723,000 | +24.9% | 1,905 | +7.6% | 0.34% | +21.4% |
| FDX | Buy | FedEx | $700,000 | +19.7% | 2,345 | +13.8% | 0.33% | +16.7% |
| New | Teledyne Technologies | $281,000 | – | 671 | +100.0% | 0.13% | – | |
| VRSN | New | Verisign | $228,000 | – | 1,000 | +100.0% | 0.11% | – |
| BX | New | Blackstone Group | $220,000 | – | 2,265 | +100.0% | 0.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Johnson & Johnson | 43 | Q2 2024 | 17.3% |
| JPMorgan Chase | 43 | Q2 2024 | 8.0% |
| Exxon Mobil | 43 | Q2 2024 | 9.3% |
| Pfizer | 43 | Q2 2024 | 6.0% |
| Procter & Gamble | 43 | Q2 2024 | 4.8% |
| Bristol-Myers Squibb | 43 | Q2 2024 | 4.1% |
| Nestle ADR | 43 | Q2 2024 | 3.4% |
| PepsiCo | 43 | Q2 2024 | 3.4% |
| Intel | 43 | Q2 2024 | 3.3% |
| Disney | 43 | Q2 2024 | 3.1% |
View Pettee Investors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-02 |
| 13F-HR | 2024-05-09 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-10-20 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-07-25 |
| 13F-HR | 2022-05-16 |
View Pettee Investors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.